Achieve Life Sciences Files 8-K: Material Agreement & Other Events
Ticker: ACHV · Form: 8-K · Filed: Jun 27, 2025 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-events, filing
Related Tickers: ACHV
TL;DR
ACHV filed an 8-K for a material definitive agreement and other events.
AI Summary
On June 26, 2025, Achieve Life Sciences, Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements and exhibits. Achieve Life Sciences, Inc. is incorporated in Delaware and has its principal executive offices in Bothell, WA, with a secondary address in Vancouver, BC, Canada.
Why It Matters
This filing indicates a significant new agreement for Achieve Life Sciences, Inc., which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the nature of these events requires further investigation.
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Bothell, WA (location) — Address of Principal Executive Offices
- Vancouver, BC, Canada (location) — Secondary address
- ONCOGENEX PHARMACEUTICALS, INC. (company) — Former company name
- SONUS PHARMACEUTICALS INC (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Achieve Life Sciences, Inc. on June 26, 2025?
The filing states that Achieve Life Sciences, Inc. entered into a material definitive agreement on June 26, 2025, but the specific details of this agreement are not provided in the provided text.
What other events are reported in this 8-K filing?
The filing indicates 'Other Events' were reported, but the specific nature of these events is not detailed in the provided text.
What financial statements and exhibits are included with this filing?
The filing mentions 'Financial Statements and Exhibits' were included, but the content of these is not specified in the provided text.
When was Achieve Life Sciences, Inc. incorporated and in which state?
Achieve Life Sciences, Inc. was incorporated in Delaware.
What were the former names of Achieve Life Sciences, Inc.?
The former names of Achieve Life Sciences, Inc. were ONCOGENEX PHARMACEUTICALS, INC. and SONUS PHARMACEUTICALS INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding ACHIEVE LIFE SCIENCES, INC. (ACHV).